These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 2494269)

  • 1. Mechanisms of bacterial opsonization by immune globulin intravenous: correlation of complement consumption with opsonic activity and protective efficacy.
    Yang KD; Bathras JM; Shigeoka AO; James J; Pincus SH; Hill HR
    J Infect Dis; 1989 Apr; 159(4):701-7. PubMed ID: 2494269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of immune globulin intravenous on opsonization of bacteria by classic and alternative complement pathways in premature serum.
    Shaio MF; Yang KD; Bohnsack JF; Hill HR
    Pediatr Res; 1989 Jun; 25(6):634-40. PubMed ID: 2662129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protective and opsonic activities of a native, pH 4.25 intravenous immunoglobulin G preparation against common bacterial pathogens.
    Hill HR; Bathras JM
    Rev Infect Dis; 1986; 8 Suppl 4():S396-400. PubMed ID: 3092306
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibronectin enhances the opsonic and protective activity of monoclonal and polyclonal antibody against group B streptococci.
    Hill HR; Shigeoka AO; Augustine NH; Pritchard D; Lundblad JL; Schwartz RS
    J Exp Med; 1984 Jun; 159(6):1618-28. PubMed ID: 6374010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Therapeutic effectiveness of an intravenous immunoglobulin with pH 4.25 in experimental neonatal sepsis caused by Klebsiella pneumoniae].
    Mancilla-Ramírez J; Nurko-Shein S; Castellanos-Cruz C; Santos-Preciado JI
    Bol Med Hosp Infant Mex; 1989 Feb; 46(2):89-93. PubMed ID: 2496700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blocking of antibody complement-dependent effector functions by streptococcal IgG Fc-receptor and staphylococcal protein A.
    Schalén C; Truedsson L; Christensen KK; Christensen P
    Acta Pathol Microbiol Immunol Scand B; 1985 Dec; 93(6):395-400. PubMed ID: 3914819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional characteristics of a modified immunoglobulin preparation for intravenous administration: summary of studies of opsonic and protective activity against group B streptococci.
    Fischer GW; Wilson SR; Hunter KW
    J Clin Immunol; 1982 Apr; 2(2 Suppl):31S-35S. PubMed ID: 7045156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity in opsonic requirements of Staphylococcus epidermidis: relative importance of surface hydrophobicity, capsules and slime.
    van Bronswijk H; Verbrugh HA; Heezius HC; Renders NH; Fleer A; van der Meulen J; Oe PL; Verhoef J
    Immunology; 1989 May; 67(1):81-6. PubMed ID: 2737697
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance to phagocytosis by group A streptococci: failure of deposited complement opsonins to interact with cellular receptors.
    Weis JJ; Law SK; Levine RP; Cleary PP
    J Immunol; 1985 Jan; 134(1):500-5. PubMed ID: 3880574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between opsonic activity for various microorganisms and composition of gammaglobulin preparations for intravenous use.
    van Furth R; Leijh PC; Klein F
    J Infect Dis; 1984 Apr; 149(4):511-7. PubMed ID: 6202804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic variability of X-protein expression by mastitis-causing Streptococcus agalactiae of serotype NT/X and opsonic activities of specific antibodies.
    Rainard P; Sarradin P; Poutrel B
    Microb Pathog; 1994 May; 16(5):359-72. PubMed ID: 7815919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opsonin-dependent and independent surface phagocytosis of S. aureus proceeds independently of complement and complement receptors.
    Gordon DL; Rice JL
    Immunology; 1988 Aug; 64(4):709-14. PubMed ID: 2971611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Opsonic activity of immunoglobulin prepared for intravenous use.
    Hetherington SV; Giebink GS
    J Lab Clin Med; 1984 Dec; 104(6):977-86. PubMed ID: 6502004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoglobulins and their receptors, and subversion of their protective roles by bacterial pathogens.
    Woof JM
    Biochem Soc Trans; 2016 Dec; 44(6):1651-1658. PubMed ID: 27913674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opsonic activity of a new intravenous immunoglobulin preparation: Pentaglobin compared with sandoglobulin.
    Garbett ND; Munro CS; Cole PJ
    Clin Exp Immunol; 1989 Apr; 76(1):8-12. PubMed ID: 2500275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of fibronectin on the interaction of polymorphonuclear leukocytes with unopsonized and antibody-opsonized bacteria.
    Yang KD; Augustine NH; Gonzalez LA; Bohnsack JF; Hill HR
    J Infect Dis; 1988 Oct; 158(4):823-30. PubMed ID: 2844920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of antibody concentration on opsonic requirements for phagocytosis in vitro of Streptococcus pneumoniae types 7 and 19.
    Chudwin DS; Wara DW; Lameris-Martin NB; Ammann AJ
    Proc Soc Exp Biol Med; 1983 Feb; 172(2):178-86. PubMed ID: 6402784
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Opsonization of bacteroides by the alternative complement pathway reconstructed from isolated plasma proteins.
    Bjornson AB; Magnafichi PI; Schreiber RD; Bjornson HS
    J Exp Med; 1987 Mar; 165(3):777-98. PubMed ID: 3819646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement-mediated phagocytosis of Pseudomonas aeruginosa.
    Peterson PK; Kim Y; Schmeling D; Lindemann M; Verhoef J; Quie PG
    J Lab Clin Med; 1978 Dec; 92(6):883-94. PubMed ID: 105067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opsonic activity of specific human IgG against Helicobacter pylori.
    Tosi MF; Czinn SJ
    J Infect Dis; 1990 Jul; 162(1):156-62. PubMed ID: 2355192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.